GlassScriptPhysician profile
Tracy M Donovan
NPI 1174025662
$682.08
in general payments reported to CMS, 2019-2025
12 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $374 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.09 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $147.05 | 2024-2025 | Vyloy |
| Lilly USA, LLC | $110.40 | 2024 | Jaypirca, Retevmo, Verzenio |
| Astrazeneca Pharmaceuticals LP | $103.97 | 2024-2025 | Calquence |
| Novartis Pharmaceuticals Corporation | $80.79 | 2024-2025 | |
| Daiichi Sankyo INC. | $48.73 | 2025 | Enhertu |
| Tempus Ai, INC | $38.58 | 2024-2025 | Xt Cdx |
| Genentech USA, INC. | $34.05 | 2024 | Venclexta |
| Incyte Corporation | $28.58 | 2025 | Zynyz, Monjuvi |
| Celgene Corporation | $27.04 | 2025 | Reblozyl |
| Eisai INC. | $24.77 | 2024 | |
| Adaptive Biotechnologies Corporation | $19.86 | 2024 | Clonoseq |
| Gilead Sciences, INC. | $18.26 | 2025 | Trodelvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.